SCHEMBL7235459

SCHEMBL7235459

CCN(CC)c1cccc(Nc2ncc(C#N)s2)n1

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDR P35968 18/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7237192 0.86 KDR (0.59) KDR
SCHEMBL7227402 0.79 KDR (0.63) KDR
SCHEMBL7237808 0.79 KDR (0.56) KDR
SCHEMBL6181222 0.76 KDR (0.59) KDR
SCHEMBL6179530 0.76 KDR (0.59) KDR
SCHEMBL6179910 0.72 KDR (1.00) KDR
SCHEMBL7235273 0.71 KDR (0.56) KDR
SCHEMBL7235039 0.70 KDR (0.62) KDR
SCHEMBL7235045 0.70 KDR (0.55) KDR
SCHEMBL5889033 0.69 KDR (1.00) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586424-B2 Anticancer agents; anticholesterol agents MERCK & CO., INC. 2003-07-01 US disclosed
US-6586423-B2 2-(Pyridin-2-ylamino)-thiazole-5-carbonitrile derivatives; angiogenesis inhibitors; antitumor and anticarcinogenic agents; atherosclerosis, macular degeneration, diabetic retinopathy MERCK & CO., INC. 2003-07-01 US disclosed